142 related articles for article (PubMed ID: 18642114)
1. Lysophosphatidic acid up-regulates vascular endothelial growth factor-C and lymphatic marker expressions in human endothelial cells.
Lin CI; Chen CN; Huang MT; Lee SJ; Lin CH; Chang CC; Lee H
Cell Mol Life Sci; 2008 Sep; 65(17):2740-51. PubMed ID: 18642114
[TBL] [Abstract][Full Text] [Related]
2. Lysophosphatidic acid upregulates vascular endothelial growth factor-C and tube formation in human endothelial cells through LPA(1/3), COX-2, and NF-kappaB activation- and EGFR transactivation-dependent mechanisms.
Lin CI; Chen CN; Huang MT; Lee SJ; Lin CH; Chang CC; Lee H
Cell Signal; 2008 Oct; 20(10):1804-14. PubMed ID: 18627789
[TBL] [Abstract][Full Text] [Related]
3. Lysophosphatidic acid enhances vascular endothelial growth factor-C expression in human prostate cancer PC-3 cells.
Lin CE; Chen SU; Lin CC; Chang CH; Lin YC; Tai YL; Shen TL; Lee H
PLoS One; 2012; 7(7):e41096. PubMed ID: 22911748
[TBL] [Abstract][Full Text] [Related]
4. Lysophosphatidic acid induces lymphangiogenesis and IL-8 production in vitro in human lymphatic endothelial cells.
Mu H; Calderone TL; Davies MA; Prieto VG; Wang H; Mills GB; Bar-Eli M; Gershenwald JE
Am J Pathol; 2012 May; 180(5):2170-81. PubMed ID: 22465753
[TBL] [Abstract][Full Text] [Related]
5. Lymphatic reprogramming of microvascular endothelial cells by CEA-related cell adhesion molecule-1 via interaction with VEGFR-3 and Prox1.
Kilic N; Oliveira-Ferrer L; Neshat-Vahid S; Irmak S; Obst-Pernberg K; Wurmbach JH; Loges S; Kilic E; Weil J; Lauke H; Tilki D; Singer BB; Ergün S
Blood; 2007 Dec; 110(13):4223-33. PubMed ID: 17761831
[TBL] [Abstract][Full Text] [Related]
6. LPA
Lin YC; Chen CC; Chen WM; Lu KY; Shen TL; Jou YC; Shen CH; Ohbayashi N; Kanaho Y; Huang YL; Lee H
Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Oct; 1863(10):1305-1315. PubMed ID: 30053596
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-1β expression is required for lysophosphatidic Acid-induced lymphangiogenesis in human umbilical vein endothelial cells.
Lin CH; Lu J; Lee H
Int J Inflam; 2010 Aug; 2011():351010. PubMed ID: 21151531
[TBL] [Abstract][Full Text] [Related]
8. Lysophosphatidic acid does not cause blood/lymphatic vessel plasticity in the rat mesentery culture model.
Sweat RS; Azimi MS; Suarez-Martinez AD; Katakam P; Murfee WL
Physiol Rep; 2016 Jul; 4(13):. PubMed ID: 27401461
[TBL] [Abstract][Full Text] [Related]
9. The potential lymphangiogenic effects of hepatocyte growth factor/scatter factor in vitro and in vivo.
Jiang WG; Davies G; Martin TA; Parr C; Watkins G; Mansel RE; Mason MD
Int J Mol Med; 2005 Oct; 16(4):723-8. PubMed ID: 16142411
[TBL] [Abstract][Full Text] [Related]
10. Blockade of FLT4 suppresses metastasis of melanoma cells by impaired lymphatic vessels.
Lee JY; Hong SH; Shin M; Heo HR; Jang IH
Biochem Biophys Res Commun; 2016 Sep; 478(2):733-8. PubMed ID: 27507214
[TBL] [Abstract][Full Text] [Related]
11. Inflammation induces lymphangiogenesis through up-regulation of VEGFR-3 mediated by NF-kappaB and Prox1.
Flister MJ; Wilber A; Hall KL; Iwata C; Miyazono K; Nisato RE; Pepper MS; Zawieja DC; Ran S
Blood; 2010 Jan; 115(2):418-29. PubMed ID: 19901262
[TBL] [Abstract][Full Text] [Related]
12. Sunitinib inhibits lymphatic endothelial cell functions and lymph node metastasis in a breast cancer model through inhibition of vascular endothelial growth factor receptor 3.
Kodera Y; Katanasaka Y; Kitamura Y; Tsuda H; Nishio K; Tamura T; Koizumi F
Breast Cancer Res; 2011 Jun; 13(3):R66. PubMed ID: 21693010
[TBL] [Abstract][Full Text] [Related]
13. Molecular profile and proliferative responses of rat lymphatic endothelial cells in culture.
Whitehurst B; Eversgerd C; Flister M; Bivens CM; Pickett B; Zawieja DC; Ran S
Lymphat Res Biol; 2006; 4(3):119-42. PubMed ID: 17034293
[TBL] [Abstract][Full Text] [Related]
14. High Glucose Induces VEGF-C Expression via the LPA1/3-Akt-ROS-LEDGF Signaling Axis in Human Prostate Cancer PC-3 Cells.
Huang YL; Lin YC; Lin CC; Chen WM; Chen BPC; Lee H
Cell Physiol Biochem; 2018; 50(2):597-611. PubMed ID: 30317243
[TBL] [Abstract][Full Text] [Related]
15. Suppression of lymphangiogenesis in human lymphatic endothelial cells by simultaneously blocking VEGF-C and VEGF-D/VEGFR-3 with norcantharidin.
Liu ZY; Qiu HO; Yuan XJ; Ni YY; Sun JJ; Jing W; Fan YZ
Int J Oncol; 2012 Nov; 41(5):1762-72. PubMed ID: 22922710
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanisms of cyclic phosphatidic acid-induced lymphangiogenic actions in vitro.
Okuyama K; Mizuno K; Nittami K; Sakaue H; Sato T
Microvasc Res; 2022 Jan; 139():104273. PubMed ID: 34699844
[TBL] [Abstract][Full Text] [Related]
17. Quantitative analysis of lymphangiogenic markers in human colorectal cancer.
Parr C; Jiang WG
Int J Oncol; 2003 Aug; 23(2):533-9. PubMed ID: 12851706
[TBL] [Abstract][Full Text] [Related]
18. [Morphogenesis, structure and properties of lymphatic vessels].
Ratajska A; Jankowska-Steifer E; Czarnowska E; Flaht A; Radomska-Leśniewska D
Postepy Hig Med Dosw (Online); 2012 Nov; 66():901-12. PubMed ID: 23175346
[TBL] [Abstract][Full Text] [Related]
19. Lysophosphatidic acid regulates inflammation-related genes in human endothelial cells through LPA1 and LPA3.
Lin CI; Chen CN; Lin PW; Chang KJ; Hsieh FJ; Lee H
Biochem Biophys Res Commun; 2007 Nov; 363(4):1001-8. PubMed ID: 17923111
[TBL] [Abstract][Full Text] [Related]
20. Isolation and characterization of circulating lymphatic endothelial colony forming cells.
DiMaio TA; Wentz BL; Lagunoff M
Exp Cell Res; 2016 Jan; 340(1):159-69. PubMed ID: 26597759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
